The Latest Breaking News from Medicare

A Guardian investigation finds insurer quietly paid facilities that helped it gain Medicare enrollees and reduce hospitalizations. Whistleblowers allege harm to residents

A rough earnings report raised troubling questions about UHG’s future, and so did the resignation of CEO Andrew Witty.

Justice department investigation into health insurance giant reported as company’s CEO says he will retire

UnitedHealth said it was not notified about the “supposed criminal investigation reported.”

Republicans in Congress intend to cut about US$880 billion in federal health care spending.

President Trump recently signed a wide-ranging executive order urging Congress to amend a crucial provision of a Biden-era law governing Medicare drug price negotiations, with the administration’s aim being to lower prices without kneecapping pharmaceutical industry investments in the research and development of innovative new drugs. The executive order marks…

President has directed Robert Kennedy to send price targets to industry, with slimming drugs thought to be included

Elon Musk promised $2 trillion in cuts but delivered only a tiny portion of that total. We asked seven policy experts to explain what he got wrong.

Health policy experts support the ‘most favored nation’ plan but doubt it will withstand likely legal challenges